KILITCH DRUGS (INDIA)
|
KILITCH DRUGS (INDIA) Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.27 | 19.37 | 9.08 | 6.71 | 4.73 |
| CEPS(Rs) | 9.92 | 10.01 | 5.15 | 3.72 | 2.73 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 95.15 | 157.06 | 109.40 | 93.85 | 87.43 |
| Tax Rate(%) | 22.03 | 23.43 | 29.86 | 31.06 | 35.37 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.59 | 17.14 | 15.72 | 12.70 | 9.19 |
| EBIT Margin(%) | 23.72 | 23.73 | 16.45 | 12.25 | 9.58 |
| Pre Tax Margin(%) | 22.04 | 22.41 | 12.54 | 8.61 | 8.42 |
| PAT Margin (%) | 17.18 | 17.16 | 8.79 | 5.93 | 5.44 |
| Cash Profit Margin (%) | 18.39 | 18.11 | 10.96 | 8.48 | 7.60 |
| Performance Ratios | |||||
| ROA(%) | 7.62 | 10.51 | 5.97 | 3.89 | 3.03 |
| ROE(%) | 11.07 | 14.54 | 8.43 | 5.86 | 4.73 |
| ROCE(%) | 12.37 | 16.90 | 13.30 | 10.26 | 7.26 |
| Asset Turnover(x) | 0.44 | 0.61 | 0.68 | 0.66 | 0.56 |
| Sales/Fixed Asset(x) | 4.04 | 2.30 | 1.38 | 1.27 | 1.28 |
| Working Capital/Sales(x) | 1.91 | 2.13 | 1.89 | 2.43 | 2.55 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.25 | 0.43 | 0.72 | 0.79 | 0.78 |
| Receivable days | 194.18 | 147.36 | 138.92 | 125.11 | 102.77 |
| Inventory Days | 25.97 | 19.39 | 7.13 | 9.21 | 13.72 |
| Payable days | 237.42 | 144.80 | 153.61 | 204.43 | 269.21 |
| Valuation Parameters | |||||
| PER(x) | 13.76 | 9.13 | 42.02 | 20.81 | 35.47 |
| PCE(x) | 12.86 | 17.67 | 37.04 | 18.38 | 30.11 |
| Price/Book(x) | 1.34 | 2.30 | 3.56 | 1.49 | 1.92 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.78 | 3.43 | 4.14 | 1.57 | 2.38 |
| EV/Core EBITDA(x) | 11.15 | 13.90 | 22.23 | 10.64 | 20.26 |
| EV/EBIT(x) | 11.72 | 14.46 | 25.17 | 12.85 | 24.82 |
| EV/CE(x) | 1.24 | 2.06 | 3.07 | 1.26 | 1.70 |
| M Cap / Sales | 2.36 | 3.20 | 4.06 | 1.56 | 2.29 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.85 | 17.63 | 10.58 | 22.20 | 66.71 |
| Core EBITDA Growth(%) | 4.88 | 55.99 | 39.19 | 53.96 | 68.00 |
| EBIT Growth(%) | 3.79 | 69.72 | 48.51 | 56.20 | 82.53 |
| PAT Growth(%) | 3.99 | 129.51 | 63.90 | 33.30 | 64.97 |
| EPS Growth(%) | -52.17 | 113.38 | 35.41 | 41.82 | 99.55 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.27 | 0.19 | 0.18 | 0.15 | 0.15 |
| Current Ratio(x) | 1.92 | 2.10 | 2.27 | 1.84 | 1.65 |
| Quick Ratio(x) | 1.82 | 1.91 | 2.21 | 1.81 | 1.57 |
| Interest Cover(x) | 14.08 | 17.92 | 4.21 | 3.36 | 8.22 |
| Total Debt/Mcap(x) | 0.20 | 0.08 | 0.05 | 0.10 | 0.08 |
Compare Financial Ratios of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹654.2 Cr | -1.2% | -0.5% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -1.2% |
-0.5% |
-1.4% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses
